Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Journal: Nature Communications

Published: 2018-11-07

DOI: 10.1038/s41467-018-07078-0

Affiliations: 16

Authors: 39

Go to article
Institutions FC
Center for Integrated Oncology Köln Bonn (CIO Köln Bonn), Germany 0.30
Department of Pathology, UoC, Germany 0.17
Faculty of Chemistry and Chemical Biology (CCB), TU Dortmund, Germany 0.13
Abteilung für Molekularpathologie, UoC, Germany 0.10
Department of Diagnostic and Interventional Radiology, UoC, Germany 0.08
Center for Molecular Medicine Cologne (CMMC), UoC, Germany 0.03
Klinik III für Innere Medizin - Allgemeine und interventionelle Kardiologie, Elektrophysiologie, Angiologie, Pneumologie und internistische Intensivmedizin, UoC, Germany 0.03
Klinikum Dortmund gGmbH, Germany 0.03
GFO Kliniken Troisdorf, Germany 0.03
Krankenhaus Köln-Merheim, Germany 0.03
Vall d'Hebron Institute of Oncology (VHIO), HUVH ICS, Spain 0.03
Netherlands Cancer Institute (NKI), Netherlands 0.03
Innere Medizin I - Onkologie, Hämatologie, Klinische Infektiologie, Klinische Immunologie, Hämostaseologie, Internistische Intensivmedizin, Germany 0.02
Cluster of Excellence - Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), UoC, Germany 0.02
University Hospital of Cologne, Germany 0.01

Return